Deal overview

Deal overview
Target DAIICHI SANKYO (DS-1062 RIGHTS)
Bidder ASTRAZENECA PLC
Price £0.00 Full version or £25.00 Light version
Publication Date Jul 27, 2020
Abstract On 27 July 2020, it was announced that the UK quoted pharmaceuticals group AstraZeneca Plc ("AstraZeneca"), had entered into a global development and commercialisation collaboration agreement with the Japanese quoted pharmaceuticals group Daiichi Sankyo Company, Limited ("Daiichi Sankyo") for DS-1062, Daiichi Sankyo's proprietary trophoblast cell-surface antigen 2 ...
Number of pages (Full version) 0
Number of pages (Light version) 2
Format Adobe Acrobat (Download Acrobat Reader)
Free Sample Click Here to Download

Purchase this report

Accepted credit cards: Visa, America Express, Master Card

Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.

Search for Deals

Search over 70 million deal reports on more than 550,000 public and private companies. (copy)

Back to search results

Page Time: 0.018907s